AIP
RAPT

Ameritas Investment Partners’s RAPT Therapeutics RAPT Stock Holding History

Ameritas Investment Partners’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-364
Closed -$3.55K – 3314
2025
Q1 		$3.55K Hold
364
– – ﹤0.01% 3026
2024
Q4 		$4.6K Hold
364
– – ﹤0.01% 3037
2024
Q3 		$5.86K Hold
364
– – ﹤0.01% 3019
2024
Q2 		$8.88K Hold
364
– – ﹤0.01% 2961
2024
Q1 		$26.2K Hold
364
– – ﹤0.01% 2453
2023
Q4 		$72.4K Hold
364
– – ﹤0.01% 1941
2023
Q3 		$48.4K Buy
364
+65
+22% +$10.6K ﹤0.01% 2127
2023
Q2 		$44.8K Hold
299
– – ﹤0.01% 2118
2023
Q1 		$43.9K Buy
299
+53
+22% +$10.7K ﹤0.01% 2054
2022
Q4 		$55.5K Hold
246
– – ﹤0.01% 1991
2022
Q3 		$47K Buy
246
+38
+18% +$7.19K ﹤0.01% 2028
2022
Q2 		$30K Hold
208
– – ﹤0.01% 2321
2022
Q1 		$37K Hold
208
– – ﹤0.01% 2238
2021
Q4 		$61K Hold
208
– – ﹤0.01% 2010
2021
Q3 		$52K Buy
208
+32
+18% +$8.46K ﹤0.01% 2129
2021
Q2 		$45K Buy
176
+55
+45% +$10.3K ﹤0.01% 2257
2021
Q1 		$22K Hold
121
– – ﹤0.01% 2527
2020
Q4 		$19K Hold
121
– – ﹤0.01% 2502
2020
Q3 		$31K Hold
121
– – ﹤0.01% 2146
2020
Q2 		$28K Buy
121
+104
+612% +$16.1K ﹤0.01% 2170
2020
Q1 		$3K Hold
17
– – ﹤0.01% 2923
2019
Q4 		$4K Buy
+17
New +$3.13K ﹤0.01% 2927

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Ameritas Investment Partners's RAPT Position: Q2 2025 in Review

Ameritas Investment Partners sold out of RAPT Therapeutics (RAPT) in Q2 2025, closing a stake of 364 shares — an estimated $3.55K sold.

Ameritas Investment Partners first reported a position in RAPT in Q4 2019 and held it in 22 quarters. The position peaked at $72.4K in Q4 2023. 50 funds tracked by Wall St. Rank hold RAPT as of Q2 2025.

  • Ameritas Investment Partners reported no remaining RAPT Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 364 RAPT Therapeutics shares in Q2 2025, an estimated $3.55K.
  • Ameritas Investment Partners first reported a position in RAPT Therapeutics in Q4 2019 and held it in 22 quarters.
  • Ameritas Investment Partners's RAPT Therapeutics position peaked at $72.4K in Q4 2023.
  • 50 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2025.

Based on Ameritas Investment Partners's 13F filing for Q2 2025, filed 12 Aug 2025.